Quality of Life Related to the Care of Women Living With HIV During the Perinatal Period
Key facts
- Where
- Paris, FranciaországSee the site
Where in Franciaország
- Hôpital Bichat - Claude-BernardParis, FranciaországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT06666530
- Record updated
- 2026. január 8.
- Original description
"The improvement of patient care by assessing the Quality of Life Related to Care (QLRC) in pregnant women living with HIV is of great importance for informing decision-making, resource allocation, and health policy formulation Prospective descriptive survey of women living with HIV followed for a pregnancy in the Infectious diseases department of Bichat-Claude Bernard Hospital, PARIS, France, between the first obstetric ultrasound and the 28th week of amenorrhea.Read full original descriptionShow less
"The improvement of patient care by assessing the Quality of Life Related to Care (QLRC) in pregnant women living with HIV is of great importance for informing decision-making, resource allocation, and health policy formulation Prospective descriptive survey of women living with HIV followed for a pregnancy in the Infectious diseases department of Bichat-Claude Bernard Hospital, PARIS, France, between the first obstetric ultrasound and the 28th week of amenorrhea.
After recruitment during a follow-up consultation:
Information regarding the prenatal and perinatal management of HIV and the infant's outcomes up to 12 months will be collected retrospectively through the medical records.
Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum."
Exclusion: Refusal to participate in the study; Non-French speaker".
"Inclusion Criteria; Woman living with HIV; Age ≥ 18 years; Pregnant - due date between the first obstetric ultrasound and 28 weeks of amenorrhea; Information provided about the study and the right to refuse participation.